Residual vein thrombosis for assessing duration of anticoagulation after unprovoked deep vein thrombosis of the lower limbs: The extended DACUS study

American Journal of Hematology

Volumn 86, Issue 11, 2011, Pages 914-917

  Siragusa, Sergio ^a   Malato, Alessandra ^a   Saccullo, Giorgia ^a   Iorio, Alfonso ^b   Di Ianni, Mauro ^c   Caracciolo, Clementina ^a   Coco, Lucio Lo ^a   Raso, Simona ^a   Santoro, Marco ^a   Guarneri, Francesco Paolo ^a   Tuttolomondo, Antonino ^a   Pinto, Antonio ^a   Pepe, Iliana ^a   Casuccio, Alessandra ^a   Abbadessa, Vincenzo ^a   Licata, Giuseppe ^a   Battista Rini, Giovan ^a   Mariani, Guglielmo ^b   Di Fede, Gaetana ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; WARFARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; HUMAN; LEG THROMBOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECURRENCE RISK; RECURRENT DISEASE; RESIDUAL VEIN THROMBOSIS; TREATMENT DURATION; TREATMENT OUTCOME; VEIN THROMBOSIS; VENOUS THROMBOEMBOLISM;

ACENOCOUMAROL; ADULT; AGED; ANTICOAGULANTS; DRUG ADMINISTRATION SCHEDULE; FEMALE; HEMORRHAGE; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; VENOUS THROMBOEMBOLISM; VENOUS THROMBOSIS; VITAMIN K; WARFARIN;

EID: 80054032981     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.22156     Document Type: Article

References (19)

1. Kearon C, Kahn SR, Agnelli G, et al. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 454S-545S
2. Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism. A population-based cohort study. Arch Intern Med 2000; 160: 761-768.
3. Kearon C, Gent M, Hirsh J, et al. A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism. N Engl J Med 1999; 340: 901-907.
4. Palareti G, Leali N, Coccheri S, et al. Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348: 423-428.
5. Kearon C, Ginsberg JS, Kovacs MJ, et al. Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism. N Engl J Med 2003; 349: 631-639.
6. Schulman S, Rhedin AS, Lindmarker P, et al. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. N Engl J Med 1995; 332: 1661-1665.
7. Palareti G, Cosmi B, Legnani C, et al. D-dimer testing to determine the duration of anticoagulation therapy. N Engl J Med 2006; 355: 1780-1789.
8. Siragusa S, Malato A, Anastasio R, et al. Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: The Duration of Anticoagulation based on Compression UltraSonography (DACUS) study. Blood 2008; 112: 511-515.
9. Prandoni P, Prins MH, Lensing AW, et al. Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: A randomized trial. Ann Intern Med 2009; 50: 577-585.
10. Cosmi B, Legnani C, Tosetto A, et al. Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: The PROLONG II prospective study. Blood 2010; 115: 481-488.
11. Carrier M, Rodger M, Wells PS, et al. Residual vein obstruction to predict the risk of recurrent venous thromboembolism in patients with deep vein thrombosis: A systematic review and meta-analysis. J Thromb Haemost 2011; 9: 1119-1125.
12. Tan M, Mos IC, Klok FA, Huisman MV. Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: A sytematic review. Br J Hematol 2011 Mar 6; doi: 10.1111/j.1365-2141.2011.08578.x. [Epub ahead of print].
13. Prandoni P, Lensing AW, Bernardi E, et al. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein thrombosis. Thromb Haemost 2002; 88: 402-406.
14. Fedullo PF, Tapson VF. The evaluation of suspected pulmonary embolism. N Engl J Med 2003; 349: 1247-1256.
15. Siragusa S, Caramazza D, Malato A. How should we determine length of anticoagulation after proximal deep vein thrombosis of the lower limbs? Br J Haematol 2009; 144: 832-837.
16. Eichinger S, Heinze G, Jandeck LM, Kyrle PA. Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism: The Vienna prediction model. Circulation 2010; 121: 1630-1636.
17. Verhovsek M, Douketis JD, Yi Q, et al. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med 2008; 149: 481-490.
18. Le Gal G, Carrier M, Kovacs MJ, et al. Residual vein obstruction as a predictor for recurrent thromboembolic events after a first unprovoked episode: Data from the REVERSE cohort study. J Thromb Haemost 2011; 9: 1126-1132.
19. Piovella F, Crippa L, Barone M, et al. Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: Association with recurrence and new thrombosis. Haematologica 2002; 87: 515-522.